
Webinar – MS-based targeted proteomics: A cornerstone to progress drug development through preclinical and clinical phases
Mass spectrometry-based targeted proteomics supports each step of drug development, from early discovery to preclinical phases and even clinical phases. End-to-end solutions range from sourcing and managing samples to standardised preparation, cutting-edge mass spectrometry, and advanced in-house data analysis. What’s more, tailored MS-based assays enable high resolution or high throughput… Read More














